Oechtering, Thekla H. http://orcid.org/0000-0002-1931-1912
Roberts, Grant S. http://orcid.org/0000-0003-1472-4352
Panagiotopoulos, Nikolaos http://orcid.org/0000-0002-3029-9360
Wieben, Oliver http://orcid.org/0000-0002-7931-1930
Roldán-Alzate, Alejandro http://orcid.org/0000-0003-4149-4038
Reeder, Scott B. http://orcid.org/0000-0003-4728-8171
Funding for this research was provided by:
national institutes of health (R01 DK096169, R01 DK125783, K24 DK102595)
deutsche forschungsgemeinschaft (OE 746/1-1)
Article History
Received: 4 August 2021
Revised: 11 November 2021
Accepted: 12 November 2021
First Online: 27 November 2021
Declarations
:
: No authors have any relevant conflicts. Unrelated to this work, Dr. Reeder has ownership interests in Calimetrix, Reveal Pharmaceuticals, Cellectar Biosciences, Elucent Medical and HeartVista.